Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Lim, Rebecca  [Clear All Filters]
2018
Lim R, Malhotra A, Tan J, Chan STeng, Lau S, Zhu D, Mockler JC, Wallace EM. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study. Stem Cells Transl Med. 2018.
2019
Baker EKate, Malhotra A, Lim R, Jacobs SE, Hooper SB, Davis PG, Wallace EM. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. BMJ Open. 2019;9(2):e026265.
2022
Ansari A, Denton KM, Lim R. Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells. Cell Biol Int. 2022.
2023
Zhu D, Barabadi M, McDonald C, Kusuma G, Inocencio IMiguel, Lim R. Implications of maternal-fetal health on perinatal stem cell banking. Gene Ther. 2023.
Keung C, Nguyen TChien, Lim R, Gerstenmaier A, Sievert W, Moore GT. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up. EBioMedicine. 2023:104879.
Phan TG, Lim R, Chan ST, McDonald H, Gan P-Y, Zhang SR, Arce LJBarreto, Vuong J, Thirugnanachandran T, Clissold B, et al. Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT). Front Neurosci. 2023;17:1153231.
2024
Lim R, Hodge A, Warner S, Moore GT, Correia J, Krause M, McDonald H, Chan ST, Goonetilleke M, Lyon SM, et al. Human amniotic epithelial cell transplantation is safe and well tolerated in patients with compensated cirrhosis: a first-in-human trial. Stem Cells Transl Med. 2024.
Barabadi M, Paton MCB, Kumar N, Lim R, Payne NL. Stem Cell Derived Extracellular Vesicle Therapy for Multiple Sclerosis, A Systematic Review and Meta-Analysis of Preclinical Studies. Stem Cells Transl Med. 2024.